Search Results 91-100 of 16348 for pharmacogenetics
Read frequently asked questions and answers about genetic testing and genetic testing results from the Mayo Clinic Center for Individualized Medicine.
The purpose of this study is to collect genetic material from individuals belonging to families with high prevalence of Type 1 Diabetes and perform whole exome ...
About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...
However, data at the three-month mark hold important implications for pharmacogenetics. In the first three months after the procedure, the TAILOR-PCI study ...
Predicting response to glucocorticoid treatment represents an unmet need. Dr. Sullivan's team plans to bridge that gap by understanding the pharmacogenetic ...
The purpose of this study is to evaluate the performance characteristics of RNA sequencing. To investigate the utility of RNA analysis in diagnosis of patients ...
The Center for Individualized Medicine aligns its programs across four pillars: Functional Omics, Digital Omics, Population Omics and Rare Disease Omics.
Lennon provided statistical expertise for a large pharmacogenetics clinical trial conducted at 40 centers worldwide. He helped plan the trial and played a ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
As genetic sequencing has become faster and cheaper, more people are considering predictive genetic testing to identify their future risk for disease, with the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.